Muna Bhanji
Director, VERACYTE, INC.
Companies
- Intellia TherapeuticsBoard member May 2, 2022 to now1
- VERACYTE, INC.Board member Mar 23, 2021 to now2
- Ardelyx (United States)Board member Mar 15, 2021 to now3
- CytokineticsBoard member Feb 18, 2021 to now4
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- VERACYTE, INC. VCYT42,718 shares5$1.9M at $45.27Sep 1, 2026
- Cytokinetics CYTK26,361 shares6$1.6M at $61.95May 27, 2026
- Ardelyx (United States) ARDX163,808 shares7$506.2K at $3.09Jun 16, 2026
Intellia Therapeutics NTLA36,403 shares8$412.8K at $11.34Jun 9, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 1, 2026Sold 1,864 shares at $42.97 of VERACYTE, INC.5
- Jun 16, 2026Granted 26,455 shares of Ardelyx (United States)7
- Jun 11, 2026Granted 5,272 shares of VERACYTE, INC.9
- Jun 9, 2026Granted 9,200 shares of Intellia Therapeutics8
- May 27, 2026Granted 2,851 shares of Cytokinetics6
- Jun 18, 2025Granted 9,321 shares of VERACYTE, INC.10
- Jun 18, 2025Granted 41,551 shares of Ardelyx (United States)11
- Jun 13, 2025Sold 4,589 shares at $26.67 of VERACYTE, INC.12
- Jun 11, 2025Granted 8,000 shares of Intellia Therapeutics13
- May 15, 2025Sold 1,454 shares at $29.73 of Cytokinetics14
- May 14, 2025Granted 7,333 shares of Cytokinetics15
- Apr 29, 2025Sold 265 shares at $8.50 of Intellia Therapeutics16
- Jan 29, 2025Sold 265 shares at $9.97 of Intellia Therapeutics17
- Jun 13, 2024Granted 11,473 shares of VERACYTE, INC.18
- Jun 12, 2024Granted 7,737 shares of Intellia Therapeutics19
- Jun 10, 2024Sold 2,000 shares at $52.07 of Cytokinetics20
- Jun 10, 2024Sold 3,870 shares at $20.32 of VERACYTE, INC.21
- May 28, 2024Sold 1,539 shares at $21.00 of VERACYTE, INC.22
- May 15, 2024Granted 5,600 shares of Cytokinetics23
- Oct 31, 2023Sold 265 shares at $23.90 of Intellia Therapeutics24
- Jul 31, 2023Sold 265 shares at $42.33 of Intellia Therapeutics25
- Jul 7, 2023Sold 2,000 shares at $34.12 of Cytokinetics26
- Jul 6, 2023Sold 1,867 shares at $39.30 of Intellia Therapeutics27
- Jun 16, 2023Sold 100 shares at $27.09 of VERACYTE, INC.28
- Jun 16, 2023Sold 5,793 shares at $26.42 of VERACYTE, INC.28
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARIntellia Therapeutics, Board member
- 2SEC EDGARVERACYTE, INC., Board member
- 3
- 4SEC EDGARCytokinetics, Board member
- 5
- 6
- 7
- 8
- 9SEC EDGARForm 4 filed Jun 15, 2026
- 10SEC EDGARForm 4 filed Jun 23, 2025
- 11SEC EDGARForm 4 filed Jun 23, 2025
- 12SEC EDGARForm 4 filed Jun 17, 2025
- 13SEC EDGARForm 4 filed Jun 13, 2025
- 14SEC EDGARForm 4 filed May 15, 2025
- 15SEC EDGARForm 4 filed May 14, 2025
- 16SEC EDGARForm 4 filed May 1, 2025
- 17SEC EDGARForm 4 filed Jan 31, 2025
- 18SEC EDGARForm 4 filed Jun 17, 2024
- 19SEC EDGARForm 4 filed Jun 14, 2024
- 20SEC EDGARForm 4 filed Jun 10, 2024
- 21SEC EDGARForm 4 filed Jun 11, 2024
- 22SEC EDGARForm 4 filed May 30, 2024
- 23SEC EDGARForm 4 filed May 16, 2024
- 24SEC EDGARForm 4 filed Nov 2, 2023
- 25SEC EDGARForm 4 filed Aug 2, 2023
- 26SEC EDGARForm 4 filed Jul 7, 2023
- 27SEC EDGARForm 4 filed Jul 10, 2023
- 28SEC EDGARForm 4 filed Jun 21, 2023